Stefan Vegter

1.8k total citations
40 papers, 1.3k citations indexed

About

Stefan Vegter is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stefan Vegter has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stefan Vegter's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Medication Adherence and Compliance (6 papers). Stefan Vegter is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Medication Adherence and Compliance (6 papers). Stefan Vegter collaborates with scholars based in Netherlands, Spain and United Kingdom. Stefan Vegter's co-authors include Maarten J. Postma, Job F. M. van Boven, Keith Tolley, Gerjan Navis, Lolkje T.W. de Jong‐van den Berg, Annalisa Perna, Thys van der Molen, Piero Ruggenenti, Giuseppe Remuzzi and Maureen Rutten‐van Mölken and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Stefan Vegter

38 papers receiving 1.3k citations

Peers

Stefan Vegter
Luca Degli Esposti Italy
William C. Gerth United States
Gerald M. Borok United States
Isabel Hurtado Spain
Marisa Battistella Canada
Mary Snowden United States
Haesuk Park United States
Valentina Perrone Italy
Jaco Voorham Netherlands
Luca Degli Esposti Italy
Stefan Vegter
Citations per year, relative to Stefan Vegter Stefan Vegter (= 1×) peers Luca Degli Esposti

Countries citing papers authored by Stefan Vegter

Since Specialization
Citations

This map shows the geographic impact of Stefan Vegter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Vegter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Vegter more than expected).

Fields of papers citing papers by Stefan Vegter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Vegter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Vegter. The network helps show where Stefan Vegter may publish in the future.

Co-authorship network of co-authors of Stefan Vegter

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Vegter. A scholar is included among the top collaborators of Stefan Vegter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Vegter. Stefan Vegter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huygens, Simone, et al.. (2021). Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision. PharmacoEconomics. 39(4). 383–397. 14 indexed citations
2.
Wilffert, Bob, Cornelis Boersma, Lieven Annemans, et al.. (2016). Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature. PLoS ONE. 11(1). e0146262–e0146262. 81 indexed citations
3.
Hatswell, Anthony J. & Stefan Vegter. (2016). Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL. Health Economics Review. 6(1). 14–14. 13 indexed citations
4.
Mera, António Galán de, Emilio González‐Parra, José Antonio Herrero, et al.. (2015). Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis. Health Economics Review. 5(1). 49–49. 6 indexed citations
5.
Denig, Petra, et al.. (2015). Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design. Current Medical Research and Opinion. 31(4). 595–602. 9 indexed citations
6.
Boven, Job F. M. van, Eline Tommelein, Koen Boussery, et al.. (2014). Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis. Respiratory Research. 15(1). 66–66. 63 indexed citations
7.
Boven, Job F. M. van, et al.. (2014). Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication. Osteoporosis International. 25(6). 1807–12. 36 indexed citations
8.
Boven, Job F. M. van, Pieter T. de Boer, Maarten J. Postma, & Stefan Vegter. (2013). Persistence with osteoporosis medication among newly-treated osteoporotic patients. Journal of Bone and Mineral Metabolism. 31(5). 562–570. 42 indexed citations
9.
Boven, Job F. M. van, Lolkje T.W. de Jong‐van den Berg, & Stefan Vegter. (2013). Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry Analysis. Drug Safety. 36(4). 231–236. 61 indexed citations
10.
11.
Boven, Job F. M. van, et al.. (2013). The pharmacists’ potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma. International Journal of Clinical Pharmacy. 35(6). 1075–1082. 17 indexed citations
12.
Vegter, Stefan, et al.. (2011). Compliance, persistence, and switching patterns for ACE inhibitors and ARBs.. PubMed. 17(9). 609–16. 27 indexed citations
13.
Vegter, Stefan, Keith Tolley, Michael W. Keith, & Maarten J. Postma. (2011). Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis. Value in Health. 14(6). 852–858. 19 indexed citations
14.
Boven, Job F. M. van, et al.. (2011). PMS42 Cost-Effectiveness of Increasing Bisphosphonates Adherence for Osteoporosis in Community Pharmacies. Value in Health. 14(7). A310–A310. 1 indexed citations
15.
Boven, Job F. M. van, et al.. (2011). PCV85 Cost-Effectiveness of Increasing Statin Adherence for Secondary Prevention in Community Pharmacies. Value in Health. 14(7). A379–A379. 3 indexed citations
16.
17.
Vegter, Stefan, et al.. (2009). Replacing hormone therapy-is the decline in prescribing sustained, and are nonhormonal drugs substituted?. Menopause The Journal of The North American Menopause Society. 16(2). 329–335. 6 indexed citations
18.
Vegter, Stefan, Annalisa Perna, Piero Ruggenenti, et al.. (2009). Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism. Pharmacogenetics and Genomics. 19(9). 695–703. 20 indexed citations
19.
Vegter, Stefan & Lolkje T.W. de Jong‐van den Berg. (2009). Misdiagnosis and mistreatment of a common side‐effect – angiotensin‐converting enzyme inhibitor‐induced cough. British Journal of Clinical Pharmacology. 69(2). 200–203. 54 indexed citations
20.
Vegter, Stefan, Cornelis Boersma, Mark H. Rozenbaum, et al.. (2008). Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes. PharmacoEconomics. 26(7). 569–587. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Degli Esposti Breakdown of academic impact, for papers by William C. Gerth Breakdown of academic impact, for papers by Gerald M. Borok Breakdown of academic impact, for papers by Isabel Hurtado Breakdown of academic impact, for papers by Marisa Battistella Breakdown of academic impact, for papers by Mary Snowden Breakdown of academic impact, for papers by Haesuk Park Breakdown of academic impact, for papers by Valentina Perrone Breakdown of academic impact, for papers by Jaco Voorham
Rankless by CCL
2026